BIIB  valuation analysis

Basics
Name: Biogen Inc
Description: Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. (more)
Industry: Drug Manufacturers-General
Last 10Q10Qs are quarterly reports which contain a company's financial figures. We use these to calculate the FFER.: Apr 22, 2021
Market cap: $58.93B (88th)
Sales(TTM): $12.60B (147th)
Earnings(TTM): $3.07B (63rd)

Value
FFER: 1.32 (why)
Actual price: $391.31
FFEThis is Biogen Inc's the estimated price. FFEs are the denominator of the FFER ratio.: $202.79
Quantile: BIIB is expensive given its fundamentals.
Prices as of EOD 2021-06-16
Price & Estimates
Sales & Earnings history (TTM)
Notable
No notables found through heuristics.
Earnings / MarketCap
Biogen Inc
"Drug Manufacturers-General" industry
Sales / MarketCap
Biogen Inc
"Drug Manufacturers-General" industry
Book / MarketCap
Biogen Inc
"Drug Manufacturers-General" industry
Equity / Assets
Biogen Inc
"Drug Manufacturers-General" industry